InVasc Therapeutics, Inc. – Product Pipeline Review – Q1 2011 by GlobalMarketsDirect

VIEWS: 4 PAGES: 22

InVasc Therapeutics, Inc. – Product Pipeline Review – Q1 2011

Summary

Global Market Direct’s pharmaceuticals report, “InVasc Therapeutics, Inc. - Product Pipeline Review - Q1 2011” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- InVasc Therapeutics, Inc. - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of InVasc Therapeutics, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of InVasc Therapeutics, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the InVasc Therapeutics, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate InVasc Therapeutics, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of InVasc Therapeutics, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the InVasc Therapeutics, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
-

More Info
									 InVasc Therapeutics, Inc. – Product Pipeline Review –
                        Q1 2011
                                                                                          Reference Code: GMDHC1099CDB

                                                                                               Publication Date: MAR 2011




InVasc Therapeutics, Inc. – Product Pipeline Review – Q1 2011                               GMDHC1099CDB / Published MAR 2011

© Global Markets Direct. This report is a licensed product and is not to be photocopied                               Page(1)
InVasc Therapeutics, Inc. – Product Pipeline Review




Ta b le o f Co n te n ts
Table of Contents                                                                                                     2
List of Tables                                                                                                        3
List of Figures                                                                                                       3
InVasc Therapeutics, Inc. Snapshot                                                                                    4
    InVasc Therapeutics, Inc. Overview                                                                                4
    Key Information                                                                                                   4
    Key Facts                                                                                                         4
InVasc Therapeutics, Inc. – Research and Development Overview                                                         5
    Key Therapeutic Areas                                                                                             5
InVasc Therapeutics, Inc. – Pipeline Review                                                                           7
    Pipeline Products by Stage of Development                                                                         7
    Pipeline Products – Monotherapy                                                                                   8
InVasc Therapeutics, Inc. – Pipeline Products Glance                                                                  9
    InVasc Therapeutics, Inc. Clinical Stage Pipeline Products                                                        9
         Phase II Products/Combination Treatment Modalities                                                           9
    InVasc Therapeutics, Inc.–Early Stage Pipeline Products                                                          10
         Pre-Clinical Products/Combination Treatment Modalities                                                      10
InVasc Therapeutics, Inc. – Drug Profiles                                                                            11
    INV-141                                                                                                          11
         Product Description                                                                                         11
         Mechanism of Action                                                                                         11
         R&D Progress                                                                                                11
    INV-144                                                                                                          12
         Product Description                                                                                         12
         Mechanism of Action                                                                                         12
         R&D Progress                                                                                                12
    INV-155                                                                                                          13
         Product Description                                                                                         13
         Mechanism of Action                                                                                         13
         R&D Progress                                                                                                13
    INV-311                                                                                                          14
         Product Description                                                                                         14
         Mechanism of Action                                                                                         14
         R&D Progress                                                                                                14
    INV-404                                                                                                          15
         Product Description                                                                                         15
         Mechanism of Action                                                                                         15
         R&D Progress                                                                                                15
    INV-405                                                                                                          16
         Product Description                                                                                         16
         Mechanism of Action                                                                                         16
         R&D Progress                                                                                                16
InVasc Therapeutics, Inc. – Pipeline Analysis                                                                        17
    InVasc Therapeutics, Inc. – Pipeline Products by Therapeutic Class                                               17
    InVasc Therapeutics, Inc. - Pipeline Products By Target                                                          18
    InVasc Therapeutics, Inc. – Pipeline Products by Molecule Type                                                   19




InVasc Therapeutics, Inc. – Product Pipeline Review – Q1 2011                             GMDHC1099CDB / Published MAR 2011

©Global Markets Direct.. This report is a licensed product and is not to be photocopied                             Page(2)
InVasc Therapeutics, Inc. – Product Pipeline Review



InVasc Therapeutics, Inc. – Locations And Subsidiaries                                                                                                                                          20
    Head Office                                                                                                                                                                                 20
Appendix                                                                                                                                                                                        21
    Methodology                                                                                                                                                                                 21
          Coverage                                                                                                                                
								
To top